LundaGUARD - A Consortium For Fighting Infectious Agents 2020-11-02T23:00:00+00:00 A new consortium aimed at leveraging the partner's technology platforms for accelerating structure-based drug discovery targeting a “weak spot” in the Sars-CoV-2 virus replication machinery, the NSP10 protein. Read More
{{ title }} {{ datetime }} {{#slideshow}} {{/slideshow}} {{^slideshow}} {{/slideshow}} {{#gallery}} {{/gallery}} {{^ gallery }} {{/ gallery }} {{{ summary }}} Read More